AI Science Tracker
EN

Random-forest screening identifies a breast-cancer growth-suppressing role for PCAT19

Harbin Medical University · 29 Mar 2023 · biology

Discovery

Random-forest screening identifies a breast-cancer growth-suppressing role for PCAT19

Source check: Source checked. Not independent scientific confirmation.

Finding: A random-forest survival model helped prioritize lncRNAs from 1054 breast-cancer expression profiles; overlap with differential expression and a separate expression database nominated PCAT19. Knocking down PCAT19 increased proliferation in two breast-cancer cell lines, while overexpression reduced xenograft growth in mice. The work supports a preclinical growth-suppressing role, not a validated treatment. Predicted regulatory networks remain hypotheses, and inconsistent clinical-prognosis wording is not used to establish patient benefit.

Technology: Random forest survival model

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

AI contribution
Random-forest survival feature importance selected the top 10% of lncRNAs from 1054 TCGA breast-cancer profiles; intersection with differential expression and external expression evidence helped select PCAT19 for functional experiments.
Test and result
Random-forest prioritization was followed by PCAT19 knockdown in two breast-cancer cell lines and overexpression in a mouse xenograft model, supporting an effect on growth. Migration and invasion changes were not statistically significant.
Limitation / still unknown
No clinical intervention or treatment benefit is established. The paper contains inconsistent directions in its clinical-prognosis narrative and reports 151 versus 153 tissue cases in different sections; these clinical claims are not represented as validated findings. The proposed ceRNA network remains computational.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://doi.org/10.1002/cam4.5872 · https://pmc.ncbi.nlm.nih.gov/articles/PMC10242319/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 21 Nov 2026. Review scope: Exact article-front DOI/title/PMCID and publication date; full primary Methods, Results and limitations. Admission represents the model-prioritized experimental growth result; contradictory clinical prognosis descriptions are explicitly excluded from the claim..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse biology discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.